Thu, Oct 31, 2024
USFDA's VAI classification boosts Cipla’s outlook for niche drug launches, including Abraxane generic
More >
'Diwali Offer' Stocks by Anil Singhvi: Stock markets have been very volatile in last one month. Benchmark equity indices Sensex and Nifty fell in early trade even Thursday i.e. October 31, 2024. Amid this, investors are looking for stocks that can offer good return in long term.
Tue, Oct 29, 2024
Zee Business forecasts indicate a three percent year-on-year revenue increase, with Cipla’s Q2 revenue expected at Rs 6,892 crore, up from Rs 6,678 crore in the same quarter last year
Thu, May 11, 2023
How will be the results of Cipla in Q4? How will be the profits and margins in Q4? How much income is possible in the March quarter? Know full details from Nupur.
Cipla Q4 2023 preview, Cipla Q4 results date: Cipla, the global pharmaceutical company, is slated to release its March quarter numbers on May 12, 2023. The quarterly results are expected to be good at the operational level.
Tue, Mar 28, 2023
Pharma stocks were a mixed bag on Tuesday, as Sun Pharma, Lupin, Biocon, Aurobindo Pharma, Pfizer, Granules and Glaxosmith succumbed to selling pressure, and Cipla, Natco Pharma, Glenmark, Dr Reddy, Abbott India and Ipca Labs managed to eke out gains. Drug pricing regulator NPPA fixed retail prices of 25 formulations.
Trading ideas for March 28: In this edition of Traders' Diary, the Zee Business research team shares exclusive research on 20 stocks that investors and traders can track on Tuesday. Cipla, Godrej Consumer, UltraTech Cement, ONGC, AB Capital and other 15 stocks in radar today
Fri, Mar 24, 2023
Top Gainers and Losers: Sensex and Nifty ended lower under selling pressure for the second straight session to settle nearly 1 per cent lower on Friday.
Wed, Mar 15, 2023
Maruti Suzuki, Bajaj Auto, Global Surfaces, Cipla, NBCC, Railtel, Mishra Dhatu Nigam, NBCC, and Sportking among others are in focus on the back of either stock-related news or various corporate actions on Wednesday, March 15, 2023.
Africa Capitalworks is a wholly owned subsidiary of Africa Capitalworks Holdings (ACW), an investment management company incorporated in Mauritius.
Tue, Mar 14, 2023
Lupin, Sun Pharma share price: Wild swings in the Indian share market come in the backdrop of sharp falls in the global markets owing to weakness in the banking space, after the collapse of US-based startup lender Silicon Valley Bank following a failed attempt to raise capital.
Thu, Mar 09, 2023
Gainers and Losers: Snapping its three-day gaining streak, the 30-share BSE Sensex closed 541.81 points or 0.90 per cent lower at 59,806.28.
Cipla shares succumbed to selling pressure on Wednesday, after four brokerages reduced their target prices for the drug maker in two days. Analysts say concerns persist among investors about the pharma company's key manufacturing facilities.
Wed, Mar 08, 2023
Brokerages are upbeat on Bajaj Auto, L&T, Grasim and power stocks, and skeptical on Cipla. Here's a look at the ratings and target prices assigned to these stocks, and more.
Thu, Mar 02, 2023
Brokerage firms have recommended Cipla and Federal Bank stocks as they have the potential to yield up to 38% returns
Stocks to buy: Brokerage firms have recommended five stocks having the potential to yield up to 38 per cent. One may consider the brokerage recommendations for positive yield.
Tue, Feb 28, 2023
Nifty Pharma and BSE Healthcare indices were trading below the flat line as most drug makers like Cipla, Biocon, Dr Reddy’s, and Alkem among others were a mixed bag
Top Gainers & Losers: The Indian markets are not seeing respite despite the oversold positions however the pace of decline has subsided in recent sessions, according to the analyst. Asian Paints, Mahindra & Mahindra were among the top gainers on the Sensex, while Cipla tumbled most by nearly 5 per cent on the NSE today.
The National Pharmaceutical Pricing Authority (NPPA) on Monday fixed the prices under the Drugs (Price Control) Order 2013 based on the decision of the 109th authority meeting held on February 21 this year, according to a PTI report.
Tue, Feb 21, 2023
Brokerages are bullish on Nifty50 companies Bharti Airtel, Hero MotoCorp, ITC, Cipla and PowerGrid. Here's what they recommend on these and other stocks in focus on Dalal Street on Tuesday.
Mon, Feb 20, 2023
Cipla shares suffered steep losses on Feb 20 after the drug maker said US health regulator had issued eight observations on its manufacturing facility in Pitampur, Madhya Pradesh.
In the Nifty50 universe, Divi’s Labs, UltraTech Cement and Tech Mahindra emerged the top gainers whereas Adani Enterprises, Cipla and Britannia were the top laggards.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
